RESUMEN
Sleep disorders commonly exist and are the earliest clinical symptoms in Alzheimer's disease (AD). At present, the molecular mechanism of AD caused by sleep disorders is not clear. Recent studies have found that sleep disorders can promote the accumulation of beta amyloid (Aβ) in the brain to form amyloid plaques with toxic effects. The increased Aβ inhibits the synaptic transmission pathway and induces abnormal phosphorylation of tau protein, which eventually leads to synaptic dysfunction. In addition, the inflammatory and stress response induced by Aβ are also associated with AD. Therefore, the improvement of sleep disorders may be a new pathway for the treatment of AD, in which light therapy is proved to be particularly effective. This article reviewes the latest progresses in the influences of sleep disorders in pathogenesis and treatment of AD in recent years.
RESUMEN
The search for above room temperature ferromagnetism in dilute magnetic semiconductors has been intense in recent year. Arrays of perpendicular ferromagnetic nanowire/rods have recently attracted considerable interest for their potential use in many areas of advanced nanotechnology. We report a simple low-temperature chemical vapor deposition (CVD) to create self-assembled comb-like Ni-/undoped ZnO nanostructure arrays. The phases, compositions, and physical properties of the studied samples were analyzed by different techniques, including high-resolution X-ray diffraction/photoelectron spectroscopy/transmission electron microscopy, photoluminescence, and MPMS. In particular, the Ni-doped ZnO nanocombs (NCs) with ferromagnetic and superparamagnetic properties have been observed whereas undoped ZnO NCs disappear. The corresponding ferromagnetic source mechanism is discussed, in which defects such as O vacancies would play an important role.